BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

India

Quadria Capital Closes Oversubscribed $1.07B Fund III to Drive Healthcare Innovation Across India and Southeast Asia

Fund close exceeds initial target despite a challenging fundraising environment, reflecting strong investor confidence in India and Southeast Asia heal...

May 27, 2025 | News

Novo Holdings Makes First Pharmaceutical Manufacturing Investment in India with Stake in SCHOTT Poonawalla

Novo Holdings, a global life sciences investor, announced its investment in SCHOTT Poonawalla, India's leading provider of high-quality drug containment an...

May 14, 2025 | News

Colorcon Enters Exclusive Partnership with ASHA Cellulose to Expand Ethyl Cellulose Offerings Across Asia, EMEA

Colorcon, a global leader of film coating systems, specialty excipients, controlled release formulations and controlled atmosphere packaging for the health...

May 09, 2025 | News

India to Gain Faster, Affordable Access to CAR T Therapy as NKure Therapeutics Partners with CRISPR Therapeutics

CTX112™ is an off-the-shelf investigational therapy, offering the potential for faster patient access compared to current CAR T treatments....

May 08, 2025 | News

Sun Pharma and Moebius Medical Showcase Durable Pain Relief and Cartilage Protection with MM-II for Knee Osteoarthritis

Durable pain relief from a single MM-II injection and its cartilage-protective effects in OA models featured in two peer-reviewed articles - - New d...

April 25, 2025 | News

Patent Wars and Patient Lives: Inside Roche vs Natco Over Risdiplam

In a courtroom packed with legal heavyweights, global pharmaceutical giant F. Hoffmann-La Roche AG faced off against Indian generic manufac...

April 14, 2025 | Analysis

Dräger Launches Atlan® A100 Anesthesia Workstation in India to Elevate Perioperative Care

Dräger, a global leader in medical and safety technology, announces the launch of the Atlan® A100 anesthesia workstation in India, an innovative a...

April 10, 2025 | News

Shilpa Pharma’s Raichur Unit-2 in India Passes Second Straight FDA Inspection Without Observations

Shilpa Medicare announces that Shilpa Pharma Lifesciences – a wholly owned subsidiary – has successfully passed a U.S. Food and Drug Admin...

April 09, 2025 | News

How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market

In this exclusive email interaction with BioPharma APAC, Alessandra Ambruosi, Director & Head of Solid Formulations & Pharm Materia...

April 02, 2025 | Interview

Alamar Biosciences Expands APAC Presence with Five New Distribution Partnerships

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce the signing of five new dis...

March 20, 2025 | News

Formosa Pharmaceuticals and Cipla Sign Multi-Regional Licensing Deal for Ophthalmic Suspension APP13007

Taiwan-based Formosa Pharmaceuticals announced an exclusive licensing agreement with Cipla Limited referred to as "Cipla" for the commercialization of clob...

March 19, 2025 | News

Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation

What are the most significant recent breakthroughs in cell and gene therapy and how is Thermo Fisher Scientific involved in these advancements? In 2024, t...

March 14, 2025 | Interaction

Shilpa Medicare’s Nor UDCA Approved by SEC for NAFLD Treatment

Shilpa Medicare Limited , a leading API and formulation manufacturer, announces that the Subject Expert Committee (SEC) of CDSCO has approved it...

March 12, 2025 | News

ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma

As the demand for plant-based and clean-label pharmaceutical solutions grows, ACG Capsules has positioned itself at the forefront of innovation with its ve...

March 06, 2025 | Interview

Stay Connected